Multicenter cohort study demonstrates deep learning's potential for nodule detection and predicting mortality risk in high-risk adults, indicating clinical applications.
Chest radiographs (CXRs) may encode prognostic signals beyond pulmonary nodule detection. We developed LungProNet, a multimodal deep‐learning (DL) model that fuses CXR features with four epidemiologic variables (age, sex, smoking history, and family history) for pulmonary nodule detection as the primary task, with secondary validation for all‐cause and cause‐specific mortality prediction. LungProNet was trained and internally validated on Tianjin Lung Cancer Imaging Dataset (TLCID) (70/30; n = 2852/1227) and externally validated on ChestDR ( n = 4848), with stratified analyses across epidemiologic strata. Discrimination was quantified by area under the curve (AUC) (95% confidence intervals), with accuracy, sensitivity, and specificity reported, and results were benchmarked against contemporary machine learning/DL baselines. The pretrained multimodal encoder was transferred without fine‐tuning to the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) ( n = 24,697); its fused embeddings were used as covariates in Cox proportional‐hazards models, and time‐dependent AUCs were evaluated at 1–12 years. For nodule detection, AUCs were 0.979 (0.975–0.982) in TLCID and 0.849 (0.835–0.862) in ChestDR; the TLCID stratified model reached 0.990 (0.984–0.994). In PLCO, AUCs were 0.925 (0.892–0.952) for all‐cause mortality and 0.939–0.985 for cardiac‐, lung cancer‐, and Chronic Obstructive Pulmonary Disease (COPD)‐cause mortality, with robust subgroup performance. These results support CXR‐based nodule flagging within screening workflows and suggest secondary opportunistic risk stratification potential.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: